Literature DB >> 15056456

Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex.

Jeroen J M Hoozemans1, Robert Veerhuis, Annemieke J M Rozemuller, Thomas Arendt, Piet Eikelenboom.   

Abstract

In Alzheimer's disease (AD) brain, increased levels of cyclooxygenase-2 (COX-2), cell cycle markers, and p38 MAP kinase (MAPK) can be detected in neuronal cells. Besides mediating COX-2 expression, p38 MAPK is suggested to mediate cell cycle progression through phosphorylation of the retinoblastoma protein (pRb). In this study, we show that neuronal immunoreactivity for phosphorylated p38 MAPK does not correlate with COX-2 or phosphorylated pRb (ppRb) in control and AD temporal cortex. Immunoreactivity for activated p38 MAPK co-localizes with AT8 immunoreactivity and increases with the occurrence of neurofibrillary tangles and plaques. On the other hand, COX-2 immunoreactivity co-localizes and correlates with ppRb immunoreactivity in pyramidal neurons. COX-2 and ppRb do not co-localize with AT8 and decrease with increasing pathology. These results suggest that p38 MAPK does not mediate COX-2 expression and pRb inactivation, which are involved in cellular changes in pyramidal neurons early in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056456     DOI: 10.1016/j.nbd.2003.11.028

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  17 in total

1.  The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β.

Authors:  Xu Wu; Yan Lu; Yuanlin Dong; Guohua Zhang; Yiying Zhang; Zhipeng Xu; Deborah J Culley; Gregory Crosby; Edward R Marcantonio; Rudolph E Tanzi; Zhongcong Xie
Journal:  Neurobiol Aging       Date:  2010-12-28       Impact factor: 4.673

2.  Caffeine modulates tau phosphorylation and affects Akt signaling in postmitotic neurons.

Authors:  Antonio Currais; Kiyoko Kato; Leonides Canuet; Ryouhei Ishii; Toshihisa Tanaka; Masatoshi Takeda; Salvador Soriano
Journal:  J Mol Neurosci       Date:  2010-09-14       Impact factor: 3.444

Review 3.  The significance of neuroinflammation in understanding Alzheimer's disease.

Authors:  P Eikelenboom; R Veerhuis; W Scheper; A J M Rozemuller; W A van Gool; J J M Hoozemans
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

4.  Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant.

Authors:  D R Harding; S E Humphries; A Whitelaw; N Marlow; H E Montgomery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-08-11       Impact factor: 5.747

5.  Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

Authors:  M Combrinck; J Williams; M A De Berardinis; D Warden; M Puopolo; A D Smith; L Minghetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06-08       Impact factor: 10.154

6.  Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.

Authors:  Akanksha Thakur; Sandra L Siedlak; Sheronica L James; David J Bonda; Akanksha Rao; Kate M Webber; Antoni Camins; Mercé Pallàs; Gemma Casadesus; Hyoung-Gon Lee; Robert Bowser; Arun K Raina; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Prostaglandin E2 synthases in neurologic homeostasis and disease.

Authors:  M Kerry O'Banion
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-22       Impact factor: 3.072

8.  PPARγ activation prevents impairments in spatial memory and neurogenesis following transient illness.

Authors:  Brandi K Ormerod; Simon J Hanft; Aditya Asokan; Ursula Haditsch; Star W Lee; Theo D Palmer
Journal:  Brain Behav Immun       Date:  2012-10-26       Impact factor: 7.217

9.  Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease.

Authors:  Uzma A Chaudhry; Hean Zhuang; Barbara J Crain; Sylvain Doré
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

Review 10.  Emerging roles of PGE2 receptors in models of neurological disease.

Authors:  Katrin Andreasson
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-11       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.